Nirmal Bang is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 295 in its April 08, 2011 research report.
Swastika Investmart is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 239.90 in its February 10, 2011 research report.